Use of random forest in FTIR analysis of LDL cholesterol and tri-glycerides for hyperlipidemia

Biotechnology Progress
Huazhou ChenKen Cai

Abstract

A quantitative determination method for the diagnosis of hyperlipidemia was developed using Fourier transform infrared (FTIR) spectroscopy. Random forest (RF) was demonstrated as a potential multivariate algorithm for the FTIR analysis of low-density lipoprotein cholesterol (LDL-C) and tri-glycerides (TG) in human serum samples. The informative wavebands for LDL-C and TG were selected based on the Gini importance. The selected wavebands were mainly within the fingerprint region. The RF modeling results were better than those derived using PLS in validation process, because the chance for over-fitting was possibly eliminated in RF algorithm. ARF also demonstrated favorable results in the test process. The prospective model exhibited a higher than 90% true prediction in negative/positive properties for male and female samples. These clinical statistical results indicated the optimization of RF algorithm performed accurately in the FTIR determination of LDL-C and TG. RF is evaluated as a promising tool for diagnosing and controlling hyperlipidemia in populations. The parameter optimization methodology is useful in the improving model accuracy using FTIR spectroscopic technology.

References

Mar 8, 2003·Quarterly Reviews of Biophysics·Andreas Barth, Christian Zscherp
Aug 17, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·Rita M CantorAldons J Lusis
Sep 25, 2007·The Journal of Chemical Physics·Jean-Joseph Max, Camille Chapados
Aug 30, 2008·Journal of Korean Medical Science·Younsuk LeeJun Heum Yon
Dec 17, 2009·The British Journal of Nutrition·Manfred BeckmannJohn Draper
May 28, 2010·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Roberto RomeroChris Beecher
Jun 12, 2010·Journal of Pharmaceutical and Biomedical Analysis·Changyong OhHye-Jin Jeong
Mar 9, 2011·Analytical Chemistry·Zeng-Ping ChenJulian Morris
Jun 29, 2011·The Analyst·Ofelia Gabriela Meza-MárquezJorge Luis de la Rosa Arana
Feb 4, 2012·Biotechnology Progress·Nitish BhushanAnurag S Rathore
May 2, 2012·Analytical and Bioanalytical Chemistry·D Perez-GuaitaM de la Guardia
Oct 22, 2013·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Huazhou ChenQiqing Song
Jul 6, 2014·Nature Protocols·Matthew J BakerFrancis L Martin

❮ Previous
Next ❯

Citations

Dec 15, 2015·Analytical Chemistry·Thomas Wilhelm BocklitzJuergen Popp
May 29, 2021·Spectrochimica Acta. Part A, Molecular and Biomolecular Spectroscopy·Wenyu PengChao Chang

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Bioinformatics in Biomedicine

Bioinformatics in biomedicine incorporates computer science, biology, chemistry, medicine, mathematics and statistics. Discover the latest research on bioinformatics in biomedicine here.